Covalently conjugated VEGF-fibrin matrices for endothelialization

Journal of Controlled Release

Volumn 72, Issue 1-3, 2001, Pages 101-113

  Zisch, Andreas H ^a   Schenk, Ursula ^a   Schense, Jason C ^a   Sakiyama Elbert, Shelly E ^a   Hubbell, Jeffrey A ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 PLASMIN INHIBITOR[1-8]; BIOMATERIAL; BLOOD CLOTTING FACTOR 8A; FIBRIN; FIBRIN GLUE; PEPTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT DNA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 121;

AMINO ACID SEQUENCE; ARTICLE; BLOOD CLOTTING; CELL GROWTH; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ENZYME ACTIVITY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; HYDROGEL; ISCHEMIA; MITOGENESIS; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN VARIANT;

CELL DIVISION; CLONING, MOLECULAR; COAGULANTS; CROSS-LINKING REAGENTS; CULTURE TECHNIQUES; DRUG CARRIERS; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBRIN; HUMANS; HYDROGELS; LYMPHOKINES; MITOGENS; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT FUSION PROTEINS; TRANSGLUTAMINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035858291     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00266-8     Document Type: Article

References (41)

1. Site-directed neovessel formation in vivo
2. Clinical application of angiogenic growth factors and their inhibitors
3. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
4. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF as sole therapy for myocardial ischemia
5. Gene therapy for myocardial angiogenesis
6. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
7. Induction of neoangiogenesis in ischemic myocardium by human growth factors
8. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
9. Enhanced revascularization of the ischemic limb by angiogenic therapy
10. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
11. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
12. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia
13. Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis
14. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
15. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery
16. Accelerated restitution of endothelial integrity and endothelium-dependent function following phVEGF165 gene transfer
17. Stent endothelialization: Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition
18. Passivation of metallic stents following arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening
19. Experimental use of a modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart
20. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type I pretreatment
21. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor I plus heparin derived from fibrin glue suspensions
22. Vascular endothelial growth factor and heparin in a biological glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition
23. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue suspensions
24. Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices
25. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIII
26. Incorporation of heparin-binding peptides into fibrin gel enhances neurite extension - An example of designer matrices in tissue engineering
27. Enzymatic incorporation of bioactive peptides into fibrin enhances neurite extension
28. Molecular and biological properties of vascular endothelial growth factor
29. Abnormal blood vessel development and lethality in mice lacking a single VEGF allele
30. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
31. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4
32. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor
33. The carboxy-terminal domain (11-165) of vascular endothelial growth factor is critical for its mitogenic activity
34. Basic fibroblast growth factor enhances bone-graft incorporation: Dose and time dependence in rats
35. Development of fibrin derivatives for controlled release of heparin-binding growth factors
36. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms
37. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses
38. Healing of polytetrafluorethylene arterial grafts is influenced by graft porosity
39. In vitro lined endothelium: Initial integrity and ultrastructural events
40. Use of fibrin glue as substrate for in vitro endothelialization of PTFE vascular grafts
41. In vitro endothelialization of expanded polytetrafluoroethylene grafts: A clinical case report after 41 months of inplantation